Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pronia Medical Systems
AddedFeb 18, 2024
UpdatedJun 18, 2026
Pronia Medical Systems

Pronia Medical Systems

GlucoCare, a Louisville-based medical organization, offers FDA-cleared, Yale Protocol-based insulin dosing, customized to individual's insulin response.

HQ
Louisville, KY, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Pronia Medical Systems, based in Louisville, Kentucky, focuses on enhancing diabetes management through its flagship product, GlucoCare. GlucoCare is an FDA-cleared insulin dosing calculator that utilizes the Yale Protocol to provide personalized insulin recommendations. By considering current and past blood sugar levels, time between measurements, and current insulin rates, GlucoCare customizes doses based on individual insulin resistance, aiming to improve patient outcomes and streamline diabetes care.

Pronia Medical Systems has achieved significant milestones, including an agreement with TransformativeMed to integrate GlucoCare into a Cerner-based platform. Additionally, the journal Diabetes, Technology and Therapeutics published an article highlighting GlucoCare's impact. These accomplishments underscore the company's commitment to advancing diabetes treatment through innovative technology.

Pronia Medical Systems - Similar Companies

Monarch Medical Technologies logo

Monarch Medical Technologies

monarchmedtech.com

Glytec logo

Glytec

glytec.com

Hygieia logo

Hygieia

hygieia.com

Insulet logo

Insulet

insulet.com

Glycostasis logo

Glycostasis

Ingram Medical logo

Ingram Medical

Intuity Medical logo

Intuity Medical

presspogo.com

Glysens logo

Glysens

Diatech Diabetes logo

Diatech Diabetes

Wendy Novak Diabetes Institute logo

Wendy Novak Diabetes Institute

GlucoIQ logo

GlucoIQ

Glucon logo

Glucon

Glumetrics logo

Glumetrics

ProNova Solutions logo

ProNova Solutions

Diabetes Care Group logo

Diabetes Care Group

Pronia Medical Systems - Quick Facts

Who are Pronia Medical Systems' competitors?

Companies similar to Pronia Medical Systems include Monarch Medical Technologies, Glytec, Hygieia and Insulet.

When was Pronia Medical Systems founded?

Pronia Medical Systems was founded in 2007.

Where is Pronia Medical Systems' headquarters located?

Pronia Medical Systems' headquarters is located in Louisville, KY, US.

When was Pronia Medical Systems' last funding round?

Pronia Medical Systems' most recent funding round was for $300k (USD) in January 2012.

How much has Pronia Medical Systems raised to-date?

As of Jan 1, 2012, Pronia Medical Systems has raised a total of $300k (USD).

How many employees does Pronia Medical Systems have?

Pronia Medical Systems has 6 employees as of Feb 4, 2024.

Pronia Medical Systems - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
  • Software
Customer
  • Enterprise
Main Product
  • Insulin Dosing
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified